Abstract
Mitochondrial DNA (mtDNA) is a circular molecule containing 27 genes involved in mitochondrial biology and the mitochondrial energy-generating pathway, oxidative phosphorylation (OXPHOS). Alterations in mtDNA have been reported to accumulate with age and some mtDNA mutations are known to be responsible for specific degenerative diseases. Recently, somatic mtDNA variations have been described in human tumors, although their functional implications in tumorigenesis have so far not been elucidated. Given the relevance of mtDNA alterations in tumor progression, their clonal nature may allow their use as markers for tumor detection. The goal of the present review is to provide an overview of mtDNA alterations in tumors and the potential utility of mtDNA in the management of cancer patients.
Resumen
El ADN mitocondrial (ADNmt) es una molécula circular que contiene 27 genes implicados en la biología mitocondrial y en los procesos celulares generadores de energía de la oxidación fosforilativa (OXPHOS). Se ha detectado una acumulación de alteraciones en el ADNmt durante el envejecimiento y, además, mutaciones en el ADNmt son la causa de ciertas enfermedades degenerativas. Durante los últimos años se ha observado la presencia de variaciones somáticas en el ADNmt en tumores humanos, aunque todavía se desconocen sus posibles implicaciones en el desarrollo tumoral. Independientemente de la importancia de las alteraciones en el ADNmt durante el desarrollo tumoral, la naturaleza clonal de estas anormalidades las convierte en marcadores tumorales, potencialmente útiles en la detección precoz y en el seguimiento del enfermo de cáncer. La presente revisión pretende realizar una síntesis de la información acumulada hasta la fecha acerca de las alteraciones del ADNmt en tumores humanos y su posible uso en el manejo del enfermo de cáncer.
Similar content being viewed by others
References
Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290:457–65.
Andersson JO, Doolittle WF, Nesbo CL. Genomics. Are there bugs in our genome? Science 2001;292:5523.
Cavalier L, Jazin E, Jalonen P. MtDNA substitution rate and segregation of heteroplasmy in coding and noncoding regions. Hum Genet 2000;107:45–50.
Tully LA, Parsons TJ, Steighner RJ, et al. A sensitive denaturing gradient-gel electrophoresis assay reveals a high frequency of heteroplasmy in hypervariable region 1 of the human mtDNA control region. Am J Hum Genet 2000;67:432–3.
Larsson N-G, Clayton DA. Molecular genetic aspects of human mitochondrial disorders. Ann Rev Genet 1995;29:151–78.
Wallace DC. Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci USA 1994;91:8739–46.
Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 1988;242:1427–30.
Holt IJ, Harding, AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717–9.
Goto Y, Nonaka I, Horai SA. A mutation in the tRNA (Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;248:651–3.
Melov S, Shoffner JM, Kaufman DC, Wallace DC. Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. Nucleic Acids Res 1995;23:4122–6.
Smeitink J, van den Heuvel L, DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2001;2(5):342–52.
Howell N, Chinnery PF, Ghosh SS, et al. Transmission of the human mitochondrial genome. Hum Reprod 2000;15:(Suppl 2):235–45.
Polyak K, Li Y, Zhu H, et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 1998;20:291–3.
Fliss MS, Usadel H, Caballero OL, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000;287:2017–9.
Parrella P, Xiao Y, Fliss M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 2001;61:7623–6.
Jones JB, Song JJ, Hempen PM, et al. Detection of mitocondrial DNA mutations in pancreatic cancer offers a «mass»-ive advantage over detection of nuclear DNA mutations. Cancer Res 2001;61(4):1299–304.
Croteau DL, Bohr V. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 1997;272:25409–12.
Allen JA, Coombs MM. Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature 1980;287:244–5.
Backer JM, Weinstein IB. Mitochondrial DNA is a major cellular target for a dihydrodiolepoxide derivative of benzo[a]pyrene. Science 1980;209:297–9.
Kunkel TA, Loeb LA. Fidelity of mammalian DNA polymerases. Science 1981;213:765–7.
Kroemer G, Zamzani N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997;18:45–51.
Coller HA, Khrapko K, Bodyak ND, et al. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 2001;28:147–50.
Sánchez-Céspedes M, Parrella P, Nomoto S, et al. Identification of a specific mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 2001;61:7015–9.
Hauswirth WW, Clayton DA. Length heterogeneity of a conserved displacement-loop sequence in human mitochondrial DNA. Nucleic Acid Res 1985;13:8093–104.
Xu B, Clayton DA. A persistent RNA-DNA hybrid is formed during transcription at a phylogenetically conserved mitochondrial DNA sequence. Mol Cell Biol 1995; 15:580–9.
Lee DY, Clayton DA. Initiation of mitochondrial DNA replication by transcription and R-loop processing. J Biol Chem 1998;46:30614–21.
Liu VWS, Shi HH, Cheung ANY, et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 2001;61:5998–6001.
Wright JMA. A review and update of oral precancerous lesions. Tex Dent 1998;115:15–9.
Califano J, van der Riet P, Westra W, et al. Genetic progresion model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488–92.
Ha PK, Tong BC, Westra WH, et al. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin Cancer Res 2002;8:2260–5.
Marchington DR, Hartshorne GM, Barlow D, Poulton J. Homopolymeric tract heteroplasmy in mtDNA from tissues and single oocytes: support for a genetic bottle-neck. Am J Hum Genet 1997;60:408–16.
Chinnery PF, Thorburn DR, Samuels DC, et al. The inheritance of mitochondrial DNA heteroplasmy: random drift, selection or both? Trends Genet 2000;16:500–5.
Sidransky D. Emerging molecular markers of cancer. Nature Rev 2002;2:210–9.
Nomoto S, Yamashita K, Koshikawa K, Nakao A, Sidransky D. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res 2002;8:481–7.
Wallace DC, Stugard C, Murdock D, et al. Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc Natl Acad Science (USA) 1997;94:14900–5.
Sánchez-Céspedes M, Arendht SA, Piantadosi S, et al. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res 2001;61:1309–13.
Jerónimo C, Nomoto S, Caballero OL, et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 2001;20:5195–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sánchez-Céspedes, M. Mitochondrial DNA alterations in human tumors. Rev Oncol 5, 15–20 (2003). https://doi.org/10.1007/BF02712836
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02712836